ZNF471 inhibits nasopharyngeal carcinoma cell growth and stemness

Xiaodan Wang1, Minqiang Chang2, Zhuyin Wen1

  • 1Department of Otolaryngology, Huzhou,Wuxing Hospital of Chinese Medicine, Huzhou City, Zhejiang Province, China.

Insights

Zinc finger protein 471 (ZNF471) was found to inhibit nasopharyngeal carcinoma (NPC) cell growth, migration, invasion, and stemness. This suggests ZNF471 may be a potential therapeutic target for NPC treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Nasopharyngeal carcinoma (NPC) is a significant health concern.
  • Understanding the molecular mechanisms underlying NPC progression is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the role of zinc finger protein 471 (ZNF471) in nasopharyngeal carcinoma (NPC) cell growth, migration, invasion, and stemness.
  • To explore ZNF471 as a potential therapeutic target for NPC.

Main Methods:

  • Analysis of ZNF471 expression in NPC tissues using the GEO2R online dataset.
  • Transfection of ZNF471 overexpression plasmid into NPC cell lines.
  • Assessment of cell viability (CCK8), proliferation (Edu), migration (Wound Healing Assay), invasion (Transwell Assay), and stemness (Spheroid Formation Assay).
  • Western blot analysis to determine the expression of β-catenin, c-Myc, and MMP-7.

Main Results:

  • Overexpression of ZNF471 significantly inhibited NPC cell viability, proliferation, migration, invasion, and stemness.
  • ZNF471 overexpression led to reduced expression of β-catenin, c-Myc, and MMP-7.
  • These findings suggest ZNF471's inhibitory effect is linked to the Wnt/β-catenin pathway.

Conclusions:

  • ZNF471 acts as a tumor suppressor in nasopharyngeal carcinoma.
  • ZNF471 inhibits NPC cell growth, migration, invasion, and stemness, potentially by suppressing the Wnt/β-catenin pathway.
  • ZNF471 represents a promising therapeutic target for NPC treatment.